D.E. Shaw & Co
AFTR

D.E. Shaw & Co’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

D.E. Shaw & Co’s Portfolio AFTR Stock Details AFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-340,746
Closed -$3.53M – 4644
2023
Q2 		$3.53M Buy
340,746
+197,952
+139% +$2.04M ﹤0.01% 2143
2023
Q1 		$1.46M Hold
142,794
– – ﹤0.01% 2904
2022
Q4 		$1.43M Buy
142,794
+100
+0.1% +$991 ﹤0.01% 3192
2022
Q3 		$1.39M Buy
142,694
+14,694
+11% +$143K ﹤0.01% 3329
2022
Q2 		$1.24M Hold
128,000
– – ﹤0.01% 3473
2022
Q1 		$1.24M Sell
128,000
-490,000
-79% -$4.74M ﹤0.01% 3733
2021
Q4 		$6.03M Buy
+618,000
New +$6M 0.01% 2186

D.E. Shaw & Co's AFTR Position: Q3 2023 in Review

D.E. Shaw & Co sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q3 2023, closing a stake of 340,746 shares — an estimated $3.53M sold.

D.E. Shaw & Co first reported a position in AFTR in Q4 2021 and held it in 7 quarters. The position peaked at $6.03M in Q4 2021. 0 funds tracked by Wall St. Rank hold AFTR as of Q3 2023.

  • D.E. Shaw & Co reported no remaining AfterNext HealthTech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 340,746 AfterNext HealthTech Acquisition Corp shares in Q3 2023, an estimated $3.53M.
  • D.E. Shaw & Co first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's AfterNext HealthTech Acquisition Corp position peaked at $6.03M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.